Mabura 40 pen (Adalimumab PEN Others) 40mg/0.8ml

Mabura 40 pen contains Adalimumab 40mg/0.8ml in a pre-filled pen for subcutaneous use. This biologic is commonly prescribed for inflammatory conditions. Store refrigerated between 2-8°C. Keep out of direct light.

Strength

40mg/0.8ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Hetero Biopharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Adalimumab pen is used to reduce inflammation and immune system activity in conditions like rheumatoid arthritis, plaque psoriasis, and Crohn’s disease. It helps manage symptoms when other treatments have not been effective. Patients often ask what is adalimumab pen used for, and it is prescribed for moderate to severe inflammatory disorders.

Side Effects

Many users report reduced joint pain and skin irritation after starting adalimumab pen therapy. Swelling and stiffness may lessen over time with consistent use. Some experience mild injection-site reactions like redness or itching.

Precautions & Warnings

Keep the pen refrigerated and avoid freezing. Allow it to reach room temperature before use for comfort. Do not use if the liquid is cloudy or contains particles. Dispose of used pens in a sharps container as directed.

Avoid Interactions

Avoid live vaccines while using adalimumab pen due to reduced immune response. Alcohol and certain supplements may increase side effects like drowsiness. Always inform healthcare providers about all medications being taken.

References

Frequently Asked Questions

Store refrigerated between 2–8°C. Do not freeze and keep away from direct light until ready to use.

Yes, but keep it refrigerated during travel. Use a cooler bag with ice packs and avoid extreme temperatures.

Mild injection-site reactions like redness or itching may occur. Some users report headache or mild nausea.

Effects vary by condition; some users notice improvement within weeks of starting regular use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.